We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
-11.69%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.96B
AUM Growth
-$276M
Cap. Flow
+$2.54M
Cap. Flow %
0.13%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$2.64M

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$91.7K

Sector Composition

Rank Sector Weight
1 Healthcare 64.43%
2 Consumer Staples 21.09%
3 Industrials 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.21B
$1.11B 56.77%
8,663,584
-655
-0% -$91.7K
MNST icon
2
Monster Beverage
MNST
$94.3B
$414M 21.09%
9,312,976
– –
IWM icon
3
iShares Russell 2000 ETF
IWM
$79.8B
$151M 7.7%
690,000
– –
AXON
4
Axon Enterprise
AXON
$42.5B
$133M 6.78%
760,062
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$85.7M 4.37%
34,005,379
– –
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$61.8M 3.15%
867,497
+28,673
+3% +$2.64M
SER icon
7
Serina Therapeutics
SER
$30M
$2.82M 0.14%
85,219
– –

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Broadwood Capital held 7 positions worth $1.96B, down 12% from $2.24B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 68% a quarter earlier, followed by Consumer Staples and Industrials.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q3 2021, an estimated $2.64M increase.
  • Broadwood Capital's biggest Q3 2021 reduction was STAAR Surgical, cutting an estimated $91.7K.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.96B portfolio in Q3 2021.
  • Broadwood Capital opened 0 new positions and closed 0 in Q3 2021.
  • Broadwood Capital's portfolio value fell 12% quarter-over-quarter to $1.96B.

Based on Broadwood Capital's 13F filing for Q3 2021, filed 15 Nov 2021.